However, about 5% to 10% of patients with CRLF2-rearranged (CRLF2-R) ALL, particularly children, have distinctly different gene expression profiles that lack genetic alteration activating tyrosine kinase signaling [81]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.